Eric Lander piece in CELL on CRISPR draws flack

An article by Eric Lander in Cell about the identity of the heroes of CRISPR has drawn significant criticism.
One piece begins:


In a perspective piece published in Cell this week (January 14), Eric Lander, president and director of the Broad Institute of MIT and Harvard, outlined the history of achievements behind the precision gene-editing technique known as CRISPR. The problem is, the Broad is a copatentee embroiled in an intellectual property battle being investigated by the US Patent and Trademark Office (USPTO). And Lander’s Cell paper does not disclose the potential conflict of interest.



See http://www.the-scientist.com//?articles.view/articleNo/45119/title/-Heroes-of-CRISPR--Disputed/